medigraphic.com
SPANISH

Revista de Especialidades Médico-Quirúrgicas

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 3

<< Back Next >>

Rev Esp Med Quir 2018; 23 (3)

Mortality due to melanoma in Mexico increases

Hernández-Domínguez DA, Aldaco-Sarvide F, Cervantes-Sánchez G, Erazo-Valle-Solís AA, Pérez-Pérez P, Torrecillas-Torres L, Cortés-Esteban P, Juárez-Ramiro A, Díaz AG
Full text How to cite this article

Language: Spanish
References: 8
Page: 123-129
PDF size: 713.08 Kb.


Key words:

Melanoma, Mortality, Mexico.

ABSTRACT

Melanoma is the most aggressive form of skin cancer. In Mexico we do not have updated information on mortality due to this neoplasm that allows us to evaluate our actions as health professionals and/or analyze and improve the functioning of our health system. Objective: To present the evolution of melanoma mortality in Mexico during the last 19 years (1998-2016). Material and methods: The official death certificates for melanoma were analyzed from the database of the National Institute of Statistics and Geography and the population estimates and projections of the National Population Council. Results: The overall mortality rate due to melanoma in Mexico has increased by 78%. Last data available for 2016 show a national average rate of 0.57/10*5 (men: 0.65/10*5; women: 0.49/10*5); the State with the highest rate is Mexico City (1.04/10*5) and the State with the lowest rate is Coahuila (0.17/10*5); the age group most affected is that of 60 years or more, with a rate of 3.69/10*5, the mortality rate for the group of 30 to 59 years is 0.48%, which is below the national average, while the group of 0 to 29 years is the least affected, with 0.03/10*5. Conclusion: Mortality due to melanoma in Mexico has increased in the last 19 years regardless of the sex and age, which forces us to implement and restructure actions in our health system to reduce mortality, otherwise and in addition to the population epidemiological transition it will be an important health problem, both welfare and economic.


REFERENCES

  1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer (2018). Disponible en: https://gco.iarc.fr/today [Visitado el 16/02/2019].

  2. Cancer Stat Facts: Melanoma of the Skin [Internet]. EE.UU.: Surveillance, Epidemiology, and End Results Program (SEER); 1975 [Actualizado 2015; citado el 13/04/2018]. Disponible en: https://seer.cancer.gov/statfacts/ html/melan.html

  3. Organización Mundial de la Salud. Clasificación internacional de enfermedades. Décima revisión. Ginebra: Organización Mundial de la Salud; 1994

  4. México en cifras [Internet]. México: Instituto Nacional de Estadística y Geografía; 2018 [fecha de acceso: 12/03/2018]. Disponible en: http:// www.inegi.org.mx

  5. Consejo Nacional de Población. Estimaciones y proyecciones de población (CONAPO) de la República Mexicana, 1998-2016 [Internet]. México, D.F.; 2018 [fecha de acceso: Marzo 2018]. Disponible en: http://www. conapo.gob.mxs

  6. Anuarios estadísticos [Internet]. México: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado; 1999 [actualización 26 de junio de 2017; citado el 13/03/2018]. Disponible en: https://www.gob. mx/issste/documentos/anuarios-estadisticos

  7. www.imss.gob.mx. México 1944; [actualizado Diciembre 2016; citado 21/04/2018] Disponible en: www.imss.gob.mx/sites/all/statics/pdf/transparencia/ focalizada/directorio-pot.xlsx https://es.statista.com/estadisticas/ 586056/poblacion-derechohabiente-en-el-instituto-mexicano- del-seguro-social/

  8. Aldaco-Sarvide F, Pérez-Pérez P, Cervantes-Sánchez G, Torrecillas-Torres L. Mortalidad por cáncer en México. Gac Mex Oncol. 2018;17:28-34.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Esp Med Quir. 2018;23